Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mittra

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology|July 15, 2016
Prevalence of gastrointestinal parasites in dogs of Palampur, Himachal PradeshAman Dev Moudgil, S Mittra, R K Agnihotri, et al.
Molecular Imaging and Biology|June 23, 2009
131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphomaAndrei Iagaru, Erik S Mittra, Kristen Ganjoo, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1981
The amylase-creatinine clearance ratio following cardiopulmonary bypassW R Murray, S Mittra, D Mittra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
Uncommon causes of thyrotoxicosisErik S Mittra, Ryan D Niederkohr, Cesar Rodriguez, et al.
Nuclear Medicine Communications|November 7, 2008
18F-FDG PET/CT evaluation of patients with ovarian carcinomaAndrei H Iagaru, Erik S Mittra, Iain Ross McDougall, et al.
Clinical Nuclear Medicine|October 28, 2017
Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell LymphomaLucia Baratto, Guido A Davidzon, Mateen Moghbel, et al.
Neuroendocrinology|March 21, 2021
The State of Peptide Receptor Radionuclide Therapy and Its Sequencing among Current Therapeutic Options for Gastroenteropancreatic Neuroendocrine TumorsLauren M Raymond, Tetiana Korzun, Adel Kardosh, et al.
Cancer Medicine|January 12, 2024
Establishing a robust radioligand therapy program: A practical approach for North American centersErik S Mittra, Rebecca K S Wong, Celeste Winters, et al.
Expert Review of Anticancer Therapy|May 9, 2023
Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumorsBoris G Naraev, Josh Mailman, Thorvardur R Halfdanarson, et al.
Clinical Nuclear Medicine|December 18, 2015
Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine TumorsFarshad Moradi, Mehran Jamali, Amir Barkhodari, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology|July 15, 2016
Prevalence of gastrointestinal parasites in dogs of Palampur, Himachal PradeshAman Dev Moudgil, S Mittra, R K Agnihotri, et al.
Molecular Imaging and Biology|June 23, 2009
131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphomaAndrei Iagaru, Erik S Mittra, Kristen Ganjoo, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1981
The amylase-creatinine clearance ratio following cardiopulmonary bypassW R Murray, S Mittra, D Mittra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
Uncommon causes of thyrotoxicosisErik S Mittra, Ryan D Niederkohr, Cesar Rodriguez, et al.
Nuclear Medicine Communications|November 7, 2008
18F-FDG PET/CT evaluation of patients with ovarian carcinomaAndrei H Iagaru, Erik S Mittra, Iain Ross McDougall, et al.
Clinical Nuclear Medicine|October 28, 2017
Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell LymphomaLucia Baratto, Guido A Davidzon, Mateen Moghbel, et al.
Neuroendocrinology|March 21, 2021
The State of Peptide Receptor Radionuclide Therapy and Its Sequencing among Current Therapeutic Options for Gastroenteropancreatic Neuroendocrine TumorsLauren M Raymond, Tetiana Korzun, Adel Kardosh, et al.
Cancer Medicine|January 12, 2024
Establishing a robust radioligand therapy program: A practical approach for North American centersErik S Mittra, Rebecca K S Wong, Celeste Winters, et al.
Expert Review of Anticancer Therapy|May 9, 2023
Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumorsBoris G Naraev, Josh Mailman, Thorvardur R Halfdanarson, et al.
Clinical Nuclear Medicine|December 18, 2015
Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine TumorsFarshad Moradi, Mehran Jamali, Amir Barkhodari, et al.
Pageof 6